Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milan Scheidegger

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Molecular Psychiatry|July 1, 2020
Impaired glutamate homeostasis in the nucleus accumbens in human cocaine addictionEtna J E Engeli, Niklaus Zoelch, Andreas Hock, et al.
Frontiers in Psychiatry|January 24, 2024
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjectsHelena D Aicher, Michael J Mueller, Dario A Dornbierer, et al.
Neuroimage|May 1, 2025
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other facesDila Suay, Helena D Aicher, Micheal Kometer, et al.
Frontiers in Pharmacology|December 13, 2023
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmineDario A Dornbierer, Laurenz Marten, Jovin Mueller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2018
Aberrant working memory processing in major depression: evidence from multivoxel pattern classificationMatti Gärtner, M Elisabetta Ghisu, Milan Scheidegger, et al.
Journal of Psychopharmacology (Oxford, England)|September 28, 2024
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreatDaniel Meling, Klemens Egger, Helena D Aicher, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 9, 2025
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation studyKlemens Egger, Javier Jareño Redondo, Jovin Müller, et al.
The International Journal of Neuropsychopharmacology|January 8, 2025
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trialMichael J Mueller, Helena D Aicher, Dario A Dornbierer, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Molecular Psychiatry|July 1, 2020
Impaired glutamate homeostasis in the nucleus accumbens in human cocaine addictionEtna J E Engeli, Niklaus Zoelch, Andreas Hock, et al.
Frontiers in Psychiatry|January 24, 2024
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjectsHelena D Aicher, Michael J Mueller, Dario A Dornbierer, et al.
Neuroimage|May 1, 2025
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other facesDila Suay, Helena D Aicher, Micheal Kometer, et al.
Frontiers in Pharmacology|December 13, 2023
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmineDario A Dornbierer, Laurenz Marten, Jovin Mueller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 20, 2018
Aberrant working memory processing in major depression: evidence from multivoxel pattern classificationMatti Gärtner, M Elisabetta Ghisu, Milan Scheidegger, et al.
Journal of Psychopharmacology (Oxford, England)|September 28, 2024
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreatDaniel Meling, Klemens Egger, Helena D Aicher, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 9, 2025
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation studyKlemens Egger, Javier Jareño Redondo, Jovin Müller, et al.
The International Journal of Neuropsychopharmacology|January 8, 2025
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trialMichael J Mueller, Helena D Aicher, Dario A Dornbierer, et al.
Pageof 5